ZX-RT30

Each lot of this material is characterized analytically to document the identity and purity of the molecule as supplied:

• High-Performance Liquid Chromatography (HPLC): chromatographic purity verified at ≥99%.
• Mass Spectrometry (MS): molecular identity confirmed against the expected peptide mass.
• Certificate of Analysis (COA): issued per lot, documenting purity, identity, and lot-specific analytical results.

Reference molecular data, where disclosed in public chemical databases: CAS 2381089-83-2. Lot-specific values are reported on the accompanying COA.

These specifications describe the molecule in the vial. They are analytical characterizations of identity and purity only and make no claim regarding biological effect. For research use only, not for human use.

A Certificate of Analysis is available per production lot, documenting HPLC purity and mass-spectrometry identity confirmation.

View Certificates of Analysis →

For Research Use Only · Not for human or veterinary use · Not for diagnostic or therapeutic use.

References to clinical phases/studies describe the compound in independent third-party literature (e.g., ClinicalTrials.gov, PubMed) and do not represent claims, testing, or approval by Zynix Biolab.

ZX-RT30 is a synthetic single-peptide molecule characterized in the scientific literature as a triple agonist of the GIP, GLP-1, and glucagon receptors — a member of the multi-receptor (poly-agonist) incretin-mimetic peptide class studied in laboratory metabolic research.

This material is supplied solely as a research chemical for in-vitro and laboratory use. It has not been tested, validated, or approved by Zynix Biolab for any application, and no claim is made regarding biological effect. For research use only, not for human use.

For Research Use Only · Not for human or veterinary use · Not for diagnostic or therapeutic use.

In the published scientific literature, this compound has been studied in connection with the following in-vitro and laboratory research areas:

• Characterization of GIP, GLP-1, and glucagon receptor signaling and receptor pharmacology.
• Investigation of multi-receptor (poly-agonist) peptide mechanisms in laboratory metabolic models.
• Comparative structure-activity and receptor-binding research alongside other incretin-class peptides.

General laboratory bench-handling guidance for this lyophilized material:

• Storage: store the lyophilized powder at -20°C, protected from light and moisture. Avoid repeated freeze–thaw cycles.
• Reconstitution: for laboratory preparation, reconstitute with bacteriostatic water or a suitable laboratory-grade solvent; swirl gently and do not shake vigorously.
• PPE: handle using appropriate personal protective equipment (gloves, lab coat, eye protection) under standard laboratory practices.
• Post-reconstitution: keep refrigerated and use within the timeframe established by your laboratory’s protocols.

This guidance addresses laboratory handling of the material only. It is not a dosing or administration instruction. For research use only — not for human use, not for consumption.

For Research Use Only · Not for human or veterinary use · Not for diagnostic or therapeutic use.

• General receptor-pharmacology literature describes GIP, GLP-1, and glucagon receptor signaling and multi-receptor (poly-agonist) peptide mechanisms in in-vitro models.
• Lot-specific analytical results (identity and purity) are documented on the accompanying Certificate of Analysis.

Supplied for laboratory research use only — not for human use.